vs

Side-by-side financial comparison of Community West Bancshares (CWBC) and MEDIFAST INC (MED). Click either name above to swap in a different company.

MEDIFAST INC is the larger business by last-quarter revenue ($75.1M vs $38.3M, roughly 2.0× Community West Bancshares). On growth, Community West Bancshares posted the faster year-over-year revenue change (11.6% vs -36.9%). Community West Bancshares produced more free cash flow last quarter ($43.6M vs $-6.6M). Over the past eight quarters, Community West Bancshares's revenue compounded faster (36.0% CAGR vs -34.4%).

Community West Bancshares is a registered bank holding company headquartered in California. It wholly owns Community West Bank under the Bank Holding Company Act.

Medifast, Inc. is an American nutrition and weight loss company based in Baltimore, Maryland. Medifast produces, distributes, and sells weight loss and health-related products through websites, multi-level marketing, telemarketing, and franchised weight loss clinics.

CWBC vs MED — Head-to-Head

Bigger by revenue
MED
MED
2.0× larger
MED
$75.1M
$38.3M
CWBC
Growing faster (revenue YoY)
CWBC
CWBC
+48.5% gap
CWBC
11.6%
-36.9%
MED
More free cash flow
CWBC
CWBC
$50.2M more FCF
CWBC
$43.6M
$-6.6M
MED
Faster 2-yr revenue CAGR
CWBC
CWBC
Annualised
CWBC
36.0%
-34.4%
MED

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
CWBC
CWBC
MED
MED
Revenue
$38.3M
$75.1M
Net Profit
Gross Margin
69.4%
Operating Margin
40.0%
-10.4%
Net Margin
Revenue YoY
11.6%
-36.9%
Net Profit YoY
EPS (diluted)
$0.58
$-1.64

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CWBC
CWBC
MED
MED
Q4 25
$38.3M
$75.1M
Q3 25
$37.9M
$89.4M
Q2 25
$35.7M
$105.6M
Q1 25
$34.8M
$115.7M
Q4 24
$34.3M
$119.0M
Q3 24
$31.3M
$140.2M
Q2 24
$30.5M
$168.6M
Q1 24
$20.7M
$174.7M
Net Profit
CWBC
CWBC
MED
MED
Q4 25
Q3 25
$10.9M
$-2.3M
Q2 25
$7.8M
$2.5M
Q1 25
$8.3M
$-772.0K
Q4 24
Q3 24
$3.4M
$1.1M
Q2 24
$-6.3M
$-8.2M
Q1 24
$3.7M
$8.3M
Gross Margin
CWBC
CWBC
MED
MED
Q4 25
69.4%
Q3 25
69.5%
Q2 25
72.6%
Q1 25
72.8%
Q4 24
74.1%
Q3 24
75.4%
Q2 24
73.2%
Q1 24
72.8%
Operating Margin
CWBC
CWBC
MED
MED
Q4 25
40.0%
-10.4%
Q3 25
39.8%
-4.6%
Q2 25
30.2%
-1.0%
Q1 25
32.7%
-1.1%
Q4 24
31.0%
0.6%
Q3 24
13.3%
1.5%
Q2 24
-25.9%
-4.7%
Q1 24
23.2%
4.5%
Net Margin
CWBC
CWBC
MED
MED
Q4 25
Q3 25
28.7%
-2.5%
Q2 25
22.0%
2.3%
Q1 25
23.8%
-0.7%
Q4 24
Q3 24
10.8%
0.8%
Q2 24
-20.7%
-4.8%
Q1 24
17.8%
4.8%
EPS (diluted)
CWBC
CWBC
MED
MED
Q4 25
$0.58
$-1.64
Q3 25
$0.57
$-0.21
Q2 25
$0.41
$0.22
Q1 25
$0.44
$-0.07
Q4 24
$0.29
$0.08
Q3 24
$0.18
$0.10
Q2 24
$-0.33
$-0.75
Q1 24
$0.31
$0.76

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CWBC
CWBC
MED
MED
Cash + ST InvestmentsLiquidity on hand
$119.0M
$167.3M
Total DebtLower is stronger
$69.5M
Stockholders' EquityBook value
$409.6M
$198.9M
Total Assets
$3.7B
$248.0M
Debt / EquityLower = less leverage
0.17×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CWBC
CWBC
MED
MED
Q4 25
$119.0M
$167.3M
Q3 25
$121.6M
$173.5M
Q2 25
$134.4M
$162.7M
Q1 25
$148.4M
$164.6M
Q4 24
$120.4M
$162.3M
Q3 24
$149.0M
$170.0M
Q2 24
$109.7M
$163.5M
Q1 24
$61.0M
$156.4M
Total Debt
CWBC
CWBC
MED
MED
Q4 25
$69.5M
Q3 25
Q2 25
Q1 25
Q4 24
$69.9M
Q3 24
Q2 24
Q1 24
Stockholders' Equity
CWBC
CWBC
MED
MED
Q4 25
$409.6M
$198.9M
Q3 25
$397.6M
$214.7M
Q2 25
$380.0M
$216.0M
Q1 25
$372.2M
$211.0M
Q4 24
$362.7M
$210.1M
Q3 24
$363.5M
$207.3M
Q2 24
$350.2M
$205.3M
Q1 24
$211.7M
$211.0M
Total Assets
CWBC
CWBC
MED
MED
Q4 25
$3.7B
$248.0M
Q3 25
$3.6B
$268.2M
Q2 25
$3.6B
$269.3M
Q1 25
$3.6B
$280.0M
Q4 24
$3.5B
$284.2M
Q3 24
$3.5B
$291.2M
Q2 24
$3.5B
$293.5M
Q1 24
$2.4B
$302.8M
Debt / Equity
CWBC
CWBC
MED
MED
Q4 25
0.17×
Q3 25
Q2 25
Q1 25
Q4 24
0.19×
Q3 24
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CWBC
CWBC
MED
MED
Operating Cash FlowLast quarter
$46.1M
$-5.3M
Free Cash FlowOCF − Capex
$43.6M
$-6.6M
FCF MarginFCF / Revenue
113.9%
-8.8%
Capex IntensityCapex / Revenue
6.6%
1.8%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$77.7M
$1.2M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CWBC
CWBC
MED
MED
Q4 25
$46.1M
$-5.3M
Q3 25
$13.2M
$12.1M
Q2 25
$11.5M
$-3.4M
Q1 25
$11.1M
$3.4M
Q4 24
$22.2M
$-4.9M
Q3 24
$7.8M
$9.1M
Q2 24
$5.2M
$13.1M
Q1 24
$4.0M
$7.3M
Free Cash Flow
CWBC
CWBC
MED
MED
Q4 25
$43.6M
$-6.6M
Q3 25
$12.8M
$10.8M
Q2 25
$10.6M
$-4.8M
Q1 25
$10.8M
$1.9M
Q4 24
$17.2M
$-7.2M
Q3 24
$5.2M
$7.7M
Q2 24
$4.8M
$11.1M
Q1 24
$3.6M
$5.4M
FCF Margin
CWBC
CWBC
MED
MED
Q4 25
113.9%
-8.8%
Q3 25
33.7%
12.0%
Q2 25
29.6%
-4.5%
Q1 25
30.9%
1.6%
Q4 24
50.0%
-6.1%
Q3 24
16.7%
5.5%
Q2 24
15.7%
6.6%
Q1 24
17.3%
3.1%
Capex Intensity
CWBC
CWBC
MED
MED
Q4 25
6.6%
1.8%
Q3 25
1.1%
1.5%
Q2 25
2.7%
1.3%
Q1 25
0.9%
1.3%
Q4 24
14.7%
1.9%
Q3 24
8.1%
1.0%
Q2 24
1.4%
1.1%
Q1 24
2.1%
1.1%
Cash Conversion
CWBC
CWBC
MED
MED
Q4 25
Q3 25
1.21×
Q2 25
1.47×
-1.36×
Q1 25
1.33×
Q4 24
Q3 24
2.29×
8.04×
Q2 24
Q1 24
1.09×
0.88×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons